ZVRA FY 2018 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$324,000

Operating Income

-$56M

Net Income

-$56M

EPS (Diluted)

$-50.39

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$54M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$27M

Total Liabilities

$93M

Stockholders' Equity

-$67M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$324,000	-$336,000	+3.6%
Operating Income	-$56M	-$33M	-67.5%
Net Income	-$56M	-$43M	-30.1%